Jeong et al. have documented that Glr×-3/PICOT, as a putative PKC inhibitor, inhibited cardiac hypertrophy and enhanced ventricular function and cardiomyocyte contractility [39]. This evidence concerns the gene GLRX3 and cardiac hypertrophy.